Charles Arntzen

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Charles Joel Arntzen' (born 1941)[1] is a plant molecular biologist.[1]

His major contributions are in the field of "plant molecular biology and protein engineering, as well as the utilization of plant biotechnology for enhancement of food quality and value, for expression of pharmacological products in transgenic plants, and for overcoming health and agricultural constraints in the developing world."[2]

In 2011, he and his team at the Biodesign Institute were developing a vaccine for the Ebola virus using mice.[3][4][5]

He is a Regents Professor at Arizona State University, served as the founding director of the Biodesign Institute until 2003, Co-Director of the Center for Infectious Diseases and Vaccinology of that Institute until 2007.[2] He was elected member of the US National Academy of Sciences in 1983.[6] He is also a foreign fellow of the National Academy of Sciences, India.[1]


  1. ^ a b c "The National Academy of Sciences, India: Foreign Fellows". Retrieved 3 June 2018. 
  2. ^ a b "Arizona State University, The Biodesign Institute: Charles Arntzen". Retrieved 3 June 2018. 
  3. ^ "Nyet News Report (12.06.11): "Ebola vaccine developed"". Retrieved 3 June 2018. 
  4. ^ Phoolcharoen, W.; Dye, J. M.; Kilbourne, J.; Piensook, K.; Pratt, W. D.; Arntzen, C. J.; Chen, Q.; Mason, H. S.; Herbst-Kralovetz, M. M. (2011). "A nonreplicating subunit vaccine protects mice against lethal Ebola virus challenge". Proceedings of the National Academy of Sciences. 108 (51): 20695–20700. doi:10.1073/pnas.1117715108. ISSN 0027-8424. PMC 3251076Freely accessible. 
  5. ^ Phoolcharoen, Waranyoo; Bhoo, Seong H.; Lai, Huafang; Ma, Julian; Arntzen, Charles J.; Chen, Qiang; Mason, Hugh S. (2011). "Expression of an immunogenic Ebola immune complex in Nicotiana benthamiana". Plant Biotechnology Journal. 9 (7): 807–816. doi:10.1111/j.1467-7652.2011.00593.x. ISSN 1467-7644. PMC 4022790Freely accessible. 
  6. ^ "US National Academy of Sciences".